Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Neoplasm Recurrence, Local"" wg kryterium: Temat

  Lista filtrów
Wyrównaj
Wyświetlanie 1-20 z 694
Tytuł:
Efficacy and safety of laparoscopic liver resection versus radiofrequency ablation in patients with early and small hepatocellular carcinoma: an updated meta-analysis and meta-regression of observational studies.
Autorzy:
Shaaban Abdelgalil M; Faculty of Medicine, Ain-Shams University, Cairo, Egypt. .
Amer BE; Faculty of Medicine, Benha University, Benha, Egypt.
Yasen N; Faculty of Applied Medical Sciences, Misr University for Science and Technology, Cairo, Egypt.; Medical Research Group of Egypt, Negida Academy, Arlington, MA, USA.
El-Samahy M; Faculty of Medicine, Zagazig University, Zagazig, Egypt.
Awad AK; Faculty of Medicine, Ain-Shams University, Cairo, Egypt.
Elfakharany B; Faculty of Allied Medical Sciences, Pharos University, Alexandria, Egypt.
Saeed O; Faculty of Medicine, Ain-Shams University, Cairo, Egypt.
Abd-ElGawad M; Faculty of Medicine, Fayoum University, Fayoum, Egypt.
Pokaż więcej
Źródło:
World journal of surgical oncology [World J Surg Oncol] 2024 Feb 07; Vol. 22 (1), pp. 47. Date of Electronic Publication: 2024 Feb 07.
Typ publikacji:
Systematic Review; Meta-Analysis; Journal Article; Review
MeSH Terms:
Carcinoma, Hepatocellular*/surgery
Laparoscopy*/adverse effects
Laparoscopy*/methods
Liver Neoplasms*/surgery
Radiofrequency Ablation*/adverse effects
Humans ; Hepatectomy/adverse effects ; Hepatectomy/methods ; Neoplasm Recurrence, Local/epidemiology ; Neoplasm Recurrence, Local/surgery ; Retrospective Studies ; Treatment Outcome
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Carbon-ion radiotherapy for hepatocellular carcinoma with major vascular invasion: a retrospective cohort study.
Autorzy:
Kaneko T; QST Hospital, National Institutes for Quantum Science and Technology, 4-9-1 Anagawa, Inage-Ku, Chiba, 263-8555, Japan.; Department of Radiology, Division of Radiation Oncology, Yamagata University, Faculty of Medicine, Yamagata, Japan.
Makishima H; QST Hospital, National Institutes for Quantum Science and Technology, 4-9-1 Anagawa, Inage-Ku, Chiba, 263-8555, Japan.; Department of Radiation Oncology, University of Tsukuba, Tsukuba, Japan.
Wakatsuki M; QST Hospital, National Institutes for Quantum Science and Technology, 4-9-1 Anagawa, Inage-Ku, Chiba, 263-8555, Japan. .
Hiroshima Y; QST Hospital, National Institutes for Quantum Science and Technology, 4-9-1 Anagawa, Inage-Ku, Chiba, 263-8555, Japan.; Department of Radiation Oncology, University of Tsukuba, Tsukuba, Japan.; Department of Radiation Oncology, Ibaraki Prefectural Central Hospital, Ibaraki Cancer Center, Kasama, Japan.
Matsui T; QST Hospital, National Institutes for Quantum Science and Technology, 4-9-1 Anagawa, Inage-Ku, Chiba, 263-8555, Japan.; Department of Radiation Oncology, Saitama Cancer Center, Saitama, Japan.
Yasuda S; QST Hospital, National Institutes for Quantum Science and Technology, 4-9-1 Anagawa, Inage-Ku, Chiba, 263-8555, Japan.; Department of Radiation Oncology, Chiba Rosai Hospital, Chiba, Japan.
Okada NN; QST Hospital, National Institutes for Quantum Science and Technology, 4-9-1 Anagawa, Inage-Ku, Chiba, 263-8555, Japan.
Nemoto K; Department of Radiology, Division of Radiation Oncology, Yamagata University, Faculty of Medicine, Yamagata, Japan.
Tsuji H; QST Hospital, National Institutes for Quantum Science and Technology, 4-9-1 Anagawa, Inage-Ku, Chiba, 263-8555, Japan.
Yamada S; QST Hospital, National Institutes for Quantum Science and Technology, 4-9-1 Anagawa, Inage-Ku, Chiba, 263-8555, Japan.
Miyazaki M; Mita Hospital, International University of Health and Welfare, Tokyo, Japan.
Pokaż więcej
Źródło:
BMC cancer [BMC Cancer] 2024 Mar 26; Vol. 24 (1), pp. 383. Date of Electronic Publication: 2024 Mar 26.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Hepatocellular*/pathology
Liver Neoplasms*/pathology
Humans ; Middle Aged ; Aged ; Aged, 80 and over ; Retrospective Studies ; Neoplasm Invasiveness ; Neoplastic Processes ; Neoplasm Recurrence, Local/pathology ; Carbon ; Prognosis
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Extracellular vesicles as potential biomarkers for diagnosis and recurrence detection of hepatocellular carcinoma.
Autorzy:
Juratli MA; Department of General, Visceral and Transplant Surgery, Muenster University Hospital, Muenster University, Muenster, Germany. .; Department of General, Transplant and Thorax Surgery, Frankfurt University Hospital, Goethe University, VisceralFrankfurt, Germany. .
Pollmann NS; Department of General, Visceral and Transplant Surgery, Muenster University Hospital, Muenster University, Muenster, Germany.
Oppermann E; Department of General, Transplant and Thorax Surgery, Frankfurt University Hospital, Goethe University, VisceralFrankfurt, Germany.
Mohr A; Department of General, Visceral and Transplant Surgery, Muenster University Hospital, Muenster University, Muenster, Germany.
Roy D; Department of Breast Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Schnitzbauer A; Department of General, Transplant and Thorax Surgery, Frankfurt University Hospital, Goethe University, VisceralFrankfurt, Germany.
Michalik S; Department of Diagnostic and Interventional Radiology, Frankfurt University Hospital, Goethe University, Frankfurt, Germany.
Vogl T; Department of Diagnostic and Interventional Radiology, Frankfurt University Hospital, Goethe University, Frankfurt, Germany.
Stoecklein NH; General, Visceral and Pediatric Surgery, University Hospital and Medical Faculty of the Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany.
Houben P; Department of General, Visceral and Transplant Surgery, Muenster University Hospital, Muenster University, Muenster, Germany.
Katou S; Department of General, Visceral and Transplant Surgery, Muenster University Hospital, Muenster University, Muenster, Germany.
Becker F; Department of General, Visceral and Transplant Surgery, Muenster University Hospital, Muenster University, Muenster, Germany.
Hoelzen JP; Department of General, Visceral and Transplant Surgery, Muenster University Hospital, Muenster University, Muenster, Germany.
Andreou A; Department of General, Visceral and Transplant Surgery, Muenster University Hospital, Muenster University, Muenster, Germany.
Pascher A; Department of General, Visceral and Transplant Surgery, Muenster University Hospital, Muenster University, Muenster, Germany.
Bechstein WO; Department of General, Transplant and Thorax Surgery, Frankfurt University Hospital, Goethe University, VisceralFrankfurt, Germany.
Struecker B; Department of General, Visceral and Transplant Surgery, Muenster University Hospital, Muenster University, Muenster, Germany.
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2024 Mar 04; Vol. 14 (1), pp. 5322. Date of Electronic Publication: 2024 Mar 04.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Hepatocellular*/diagnosis
Liver Neoplasms*/diagnosis
Extracellular Vesicles*
Humans ; Cohort Studies ; Pilot Projects ; Prospective Studies ; Neoplasm Recurrence, Local/diagnosis ; Biomarkers
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
The impact of Karnofsky performance status on prognosis of patients with hepatocellular carcinoma in liver transplantation.
Autorzy:
Zhou J; Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, First Afliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China.
Ye D; Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, First Afliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China.
Zhang S; Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, Fourth Affiliated Hospital, School of Medicine, Zhejiang University, Yiwu, China.
Ding J; Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, Fourth Affiliated Hospital, School of Medicine, Zhejiang University, Yiwu, China.
Zhang T; Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, Fourth Affiliated Hospital, School of Medicine, Zhejiang University, Yiwu, China.
Chen Z; Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, Fourth Affiliated Hospital, School of Medicine, Zhejiang University, Yiwu, China.
Xu F; Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, Fourth Affiliated Hospital, School of Medicine, Zhejiang University, Yiwu, China.
Ren S; Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, Fourth Affiliated Hospital, School of Medicine, Zhejiang University, Yiwu, China.
Hu Z; Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, First Afliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China. .; Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, Fourth Affiliated Hospital, School of Medicine, Zhejiang University, Yiwu, China. .
Pokaż więcej
Źródło:
BMC gastroenterology [BMC Gastroenterol] 2024 Feb 26; Vol. 24 (1), pp. 85. Date of Electronic Publication: 2024 Feb 26.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Hepatocellular*/pathology
Liver Neoplasms*/pathology
Liver Transplantation*
Adult ; Humans ; Karnofsky Performance Status ; Retrospective Studies ; Neoplasm Recurrence, Local ; Prognosis ; Waiting Lists
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Impact of inflammation and the immune system on hepatocellular carcinoma recurrence after hepatectomy.
Autorzy:
She S; Department of Infectious Diseases, Renmin Hospital of Wuhan University, Wuhan, Hubei Province, China.
Shi J; Department of Infectious Diseases, Renmin Hospital of Wuhan University, Wuhan, Hubei Province, China.
Zhu J; Department of Infectious Diseases, Renmin Hospital of Wuhan University, Wuhan, Hubei Province, China.
Yang F; Department of Infectious Diseases, Renmin Hospital of Wuhan University, Wuhan, Hubei Province, China.
Yu J; Department of Hepatobiliary surgery, Renmin Hospital of Wuhan University, Wuhan, Hubei Province, China.
Dai K; Department of Infectious Diseases, Renmin Hospital of Wuhan University, Wuhan, Hubei Province, China.
Pokaż więcej
Źródło:
Cancer medicine [Cancer Med] 2024 Feb; Vol. 13 (4), pp. e7018.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Carcinoma, Hepatocellular*/pathology
Liver Neoplasms*/pathology
Humans ; Hepatectomy/adverse effects ; Neoplasm Recurrence, Local/surgery ; Inflammation/etiology ; Lymphocytes/pathology ; Biomarkers ; Retrospective Studies ; Prognosis ; Tumor Microenvironment
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Feasibility of novel intraoperative navigation for anatomical liver resection using real-time virtual sonography combined with indocyanine green fluorescent imaging technology.
Autorzy:
Pu C; Department of General Surgery, Peking University First Hospital, Beijing, China.; Department of Hepatobiliary Surgery, Peking University International Hospital, Beijing, China.
Wu T; Department of Hepatobiliary Surgery, Peking University International Hospital, Beijing, China.
Wang Q; Department of Hepatobiliary Surgery, Peking University International Hospital, Beijing, China.
Yang Y; Department of General Surgery, Peking University First Hospital, Beijing, China.
Zhang K; Department of Hepatobiliary Surgery, Peking University International Hospital, Beijing, China.
Pokaż więcej
Źródło:
Bioscience trends [Biosci Trends] 2024 Jan 30; Vol. 17 (6), pp. 484-490. Date of Electronic Publication: 2023 Dec 13.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Hepatocellular*/diagnostic imaging
Carcinoma, Hepatocellular*/surgery
Liver Neoplasms*/diagnostic imaging
Liver Neoplasms*/surgery
Humans ; Indocyanine Green ; Hepatectomy/methods ; Retrospective Studies ; Feasibility Studies ; Neoplasm Recurrence, Local/surgery ; Margins of Excision ; Postoperative Complications/surgery ; Technology
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Prognostic potential of preoperative circulating tumor cells to predict the early progression recurrence in hepatocellular carcinoma patients after hepatectomy.
Autorzy:
Lu Z; Department of Hepatobiliary Surgery, Guangxi Medical University Cancer Hospital, 71# Hedi Road, Qingxiu District, Nanning, Guangxi, 530021, People's Republic of China.; Key Laboratory of Early Prevention and Treatment for Regional High-Frequency Tumors, Ministry of Education, Nanning, People's Republic of China.; Guangxi Medical University, Nanning, People's Republic of China.
Ni H; Department of Hepatobiliary Surgery, Guangxi Medical University Cancer Hospital, 71# Hedi Road, Qingxiu District, Nanning, Guangxi, 530021, People's Republic of China.; Key Laboratory of Early Prevention and Treatment for Regional High-Frequency Tumors, Ministry of Education, Nanning, People's Republic of China.; Guangxi Medical University, Nanning, People's Republic of China.
Yang X; Department of Surgical Oncology, Chenzhou No. 1 People's Hospital, Chenzhou, People's Republic of China.
Tan L; Guangxi Medical University, Nanning, People's Republic of China.
Zhuang H; Guangxi Medical University, Nanning, People's Republic of China.
Mo Y; Guangxi Medical University, Nanning, People's Republic of China.
Wei X; Guangxi Medical University, Nanning, People's Republic of China.
Qi L; Department of Hepatobiliary Surgery, Guangxi Medical University Cancer Hospital, 71# Hedi Road, Qingxiu District, Nanning, Guangxi, 530021, People's Republic of China. qilunan_.; Key Laboratory of Early Prevention and Treatment for Regional High-Frequency Tumors, Ministry of Education, Nanning, People's Republic of China. qilunan_.; Guangxi Medical University, Nanning, People's Republic of China. qilunan_.; Guangxi Liver Cancer Diagnosis and Treatment Engineering and Technology Research Center, Nanning, People's Republic of China. qilunan_.
Xiang B; Department of Hepatobiliary Surgery, Guangxi Medical University Cancer Hospital, 71# Hedi Road, Qingxiu District, Nanning, Guangxi, 530021, People's Republic of China. .; Key Laboratory of Early Prevention and Treatment for Regional High-Frequency Tumors, Ministry of Education, Nanning, People's Republic of China. .; Guangxi Medical University, Nanning, People's Republic of China. .; Guangxi Liver Cancer Diagnosis and Treatment Engineering and Technology Research Center, Nanning, People's Republic of China. .
Pokaż więcej
Źródło:
BMC cancer [BMC Cancer] 2023 Nov 27; Vol. 23 (1), pp. 1150. Date of Electronic Publication: 2023 Nov 27.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Hepatocellular*/pathology
Liver Neoplasms*/pathology
Neoplastic Cells, Circulating*/pathology
Humans ; Prognosis ; Hepatectomy ; Neoplasm Recurrence, Local/pathology ; Retrospective Studies
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
A meta-analysis of the prognostic impact of tissue golgi protein 73 (tGP73) in hepatocellular carcinoma.
Autorzy:
Yu WM; Department of Hepatobiliary and pancreatic surgery, The First People's Hospital of Fuyang District, Fuyang First Hospital Affiliated to Binjiang College of Zhejiang Chinese Medicine University, Hangzhou, China. .
Li GW; Department of Hepatobiliary and pancreatic surgery, The First People's Hospital of Fuyang District, Fuyang First Hospital Affiliated to Binjiang College of Zhejiang Chinese Medicine University, Hangzhou, China.
Lou MG; Department of Hepatobiliary and pancreatic surgery, The First People's Hospital of Fuyang District, Fuyang First Hospital Affiliated to Binjiang College of Zhejiang Chinese Medicine University, Hangzhou, China.
Wu ZY; Department of Hepatobiliary and pancreatic surgery, The First People's Hospital of Fuyang District, Fuyang First Hospital Affiliated to Binjiang College of Zhejiang Chinese Medicine University, Hangzhou, China.
Pokaż więcej
Źródło:
BMC gastroenterology [BMC Gastroenterol] 2023 Nov 17; Vol. 23 (1), pp. 401. Date of Electronic Publication: 2023 Nov 17.
Typ publikacji:
Meta-Analysis; Journal Article
MeSH Terms:
Carcinoma, Hepatocellular*/pathology
Liver Neoplasms*/pathology
Humans ; Prognosis ; Reproducibility of Results ; Neoplasm Recurrence, Local
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Tumor necrosis as a predictor of early tumor recurrence after resection in patients with hepatoma.
Autorzy:
Yen YH; Division of Hepatogastroenterology, Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung, Taiwan.
Kuo FY; Department of Pathology, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung, Taiwan.
Eng HL; Department of Pathology, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung, Taiwan.
Liu YW; Liver Transplantation Center and Department of Surgery, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, Taiwan.
Yong CC; Liver Transplantation Center and Department of Surgery, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, Taiwan.
Li WF; Liver Transplantation Center and Department of Surgery, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, Taiwan.
Wang CC; Liver Transplantation Center and Department of Surgery, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, Taiwan.
Lin CY; Biostatistics Center of Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, Taiwan.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2023 Nov 16; Vol. 18 (11), pp. e0292144. Date of Electronic Publication: 2023 Nov 16 (Print Publication: 2023).
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Hepatocellular*/surgery
Carcinoma, Hepatocellular*/pathology
Liver Neoplasms*/surgery
Liver Neoplasms*/pathology
Humans ; Retrospective Studies ; Neoplasm Recurrence, Local/pathology ; Nomograms ; Hepatectomy ; Necrosis
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Tazemetostat decreases β-catenin and CD13 protein expression in HEPG-2 and Hepatitis B virus-transfected HEPG-2 with decreased cell viability.
Autorzy:
Amin MN; Biochemistry Department, Faculty of Pharmacy, Mansoura University, Mansoura, 35516, Egypt.
El-Far YM; Biochemistry Department, Faculty of Pharmacy, Mansoura University, Mansoura, 35516, Egypt.
El-Mowafy M; Microbiology and Immunology Department, Faculty of Pharmacy, Mansoura University, Mansoura, 35516, Egypt.
Elgaml A; Microbiology and Immunology Department, Faculty of Pharmacy, Mansoura University, Mansoura, 35516, Egypt. .; Microbiology and Immunology Department, Faculty of Pharmacy, Horus University, New Damietta, 34518, Egypt. .
Pokaż więcej
Źródło:
Clinical epigenetics [Clin Epigenetics] 2023 Nov 08; Vol. 15 (1), pp. 180. Date of Electronic Publication: 2023 Nov 08.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Carcinoma, Hepatocellular*/drug therapy
Carcinoma, Hepatocellular*/genetics
Liver Neoplasms*/drug therapy
Liver Neoplasms*/genetics
Liver Neoplasms*/metabolism
Humans ; Hepatitis B virus ; beta Catenin/genetics ; Epithelial Cell Adhesion Molecule/metabolism ; Cell Survival ; DNA Methylation ; Neoplasm Recurrence, Local ; Cell Line, Tumor
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Radiological characteristics of hepatocellular carcinoma that achieved complete response after chemoembolization with drug-eluting beads for liver transplantation planning.
Autorzy:
Valle LGM; Hospital Israelita Albert Einstein, São Paulo, SP, Brazil.
Cunha MJS; Hospital Israelita Albert Einstein, São Paulo, SP, Brazil.
Schmid BP; Hospital Israelita Albert Einstein, São Paulo, SP, Brazil.
Falsarella PM; Hospital Israelita Albert Einstein, São Paulo, SP, Brazil.
Rezende MB; Hospital Israelita Albert Einstein, São Paulo, SP, Brazil.
Felga GEG; Hospital Israelita Albert Einstein, São Paulo, SP, Brazil.
Ogawa RE; Hospital Israelita Albert Einstein, São Paulo, SP, Brazil.
Garcia RG; Hospital Israelita Albert Einstein, São Paulo, SP, Brazil.
Affonso BB; Hospital Israelita Albert Einstein, São Paulo, SP, Brazil.
Nasser F; Hospital Israelita Albert Einstein, São Paulo, SP, Brazil.
Galastri FL; Hospital Israelita Albert Einstein, São Paulo, SP, Brazil.
Pokaż więcej
Źródło:
Einstein (Sao Paulo, Brazil) [Einstein (Sao Paulo)] 2023 Oct 27; Vol. 21, pp. eAO0307. Date of Electronic Publication: 2023 Oct 27 (Print Publication: 2023).
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Hepatocellular*/diagnostic imaging
Carcinoma, Hepatocellular*/therapy
Liver Neoplasms*/diagnostic imaging
Liver Neoplasms*/therapy
Liver Transplantation*
Chemoembolization, Therapeutic*/methods
Humans ; Case-Control Studies ; Treatment Outcome ; Neoplasm Recurrence, Local/diagnostic imaging ; Neoplasm Recurrence, Local/therapy ; Retrospective Studies
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Liver resection for large and huge hepatocellular carcinoma: Predictors of failure, recurrence patterns, and prognoses.
Autorzy:
Xiang C; Department of Hepatobiliary Surgery, Affiliated Tumor Hospital of Guangxi Medical University, Nanning, China.; Department II of General Surgery, Hunan Provincial People's Hospital, The First Affiliated Hospital of Hunan Normal University, Changsha, China.
Xiao Y; School of Molecular Medicine, Hangzhou Institute for Advanced Study, UCAS, Hangzhou, China.
Ma Z; Department of Hepatobiliary Surgery, Hunan Provincial People's Hospital, The First Affiliated Hospital of Hunan Normal University, Changsha, China.
Peng Y; Department of Hepatobiliary Surgery, Affiliated Tumor Hospital of Guangxi Medical University, Nanning, China.
Li X; School of Chemical Sciences, University of Chinese Academy of Sciences, Beijing, China.
Mao X; Department of Hepatobiliary Surgery, Hunan Provincial People's Hospital, The First Affiliated Hospital of Hunan Normal University, Changsha, China.
Li L; Department of Hepatobiliary Surgery, Affiliated Tumor Hospital of Guangxi Medical University, Nanning, China.
Pokaż więcej
Źródło:
Asia-Pacific journal of clinical oncology [Asia Pac J Clin Oncol] 2023 Apr; Vol. 19 (2), pp. e60-e70. Date of Electronic Publication: 2022 Apr 11.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Hepatocellular*/mortality
Carcinoma, Hepatocellular*/surgery
Liver Neoplasms*/mortality
Liver Neoplasms*/surgery
Neoplasm Recurrence, Local*/diagnosis
Hepatectomy ; Prognosis ; Humans ; Male ; Female ; Adolescent ; Young Adult ; Adult ; Middle Aged ; Aged ; Disease-Free Survival
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Radiofrequency ablation combined with toripalimab for recurrent hepatocellular carcinoma: A prospective controlled trial.
Autorzy:
Wen Z; Department of Public Health, Jilin University, Jilin, China.
Wang J; Aerospace Medical Center, Aerospace Center Hospital, Beijing, China.
Tu B; Department of Infectious Diseases, Fifth Medical Center of Chinese PLA General Hospital, Beijing, China.
Liu Y; Department of Public Health, Jilin University, Jilin, China.
Yang Y; Department of Public Health, Jilin University, Jilin, China.
Hou L; Department of Oncology, Fifth Medical Center of Chinese PLA General Hospital, Beijing, China.
Yang X; Department of Oncology, Fifth Medical Center of Chinese PLA General Hospital, Beijing, China.
Liu X; Department of Hepatology, Fifth Medical Center of Chinese PLA General Hospital, Beijing, China.
Xie H; Department of Oncology, Fifth Medical Center of Chinese PLA General Hospital, Beijing, China.
Pokaż więcej
Źródło:
Cancer medicine [Cancer Med] 2023 Oct; Vol. 12 (20), pp. 20311-20320. Date of Electronic Publication: 2023 Oct 10.
Typ publikacji:
Controlled Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Carcinoma, Hepatocellular*/pathology
Liver Neoplasms*/surgery
Liver Neoplasms*/pathology
Radiofrequency Ablation*
Humans ; Male ; Neoplasm Recurrence, Local/surgery ; Prospective Studies ; Retrospective Studies ; Treatment Outcome ; Female ; Middle Aged
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
The aryl hydrocarbon receptor maintains antitumor activity of liver resident natural killer cells after partial hepatectomy in C57BL/6J mice.
Autorzy:
Sato K; Department of Gastroenterological and Transplant Surgery, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.
Ohira M; Department of Gastroenterological and Transplant Surgery, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.; Medical Center for Translational and Clinical Research Hiroshima University Hospital, Hiroshima, Japan.
Imaoka Y; Department of Gastroenterological and Transplant Surgery, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.
Imaoka K; Department of Gastroenterological and Transplant Surgery, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.
Bekki T; Department of Gastroenterological and Transplant Surgery, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.
Doskali M; Department of Gastroenterological and Transplant Surgery, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.
Nakano R; Department of Gastroenterological and Transplant Surgery, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.
Yano T; Department of Gastroenterological and Transplant Surgery, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.
Tanaka Y; Department of Gastroenterological and Transplant Surgery, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.
Ohdan H; Department of Gastroenterological and Transplant Surgery, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.
Pokaż więcej
Źródło:
Cancer medicine [Cancer Med] 2023 Oct; Vol. 12 (19), pp. 19821-19837. Date of Electronic Publication: 2023 Sep 25.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Carcinoma, Hepatocellular*/immunology
Carcinoma, Hepatocellular*/surgery
Killer Cells, Natural*/immunology
Receptors, Aryl Hydrocarbon*/analysis
Receptors, Aryl Hydrocarbon*/metabolism
Liver Neoplasms*/immunology
Liver Neoplasms*/surgery
Animals ; Mice ; Hepatectomy ; Mice, Inbred C57BL ; TNF-Related Apoptosis-Inducing Ligand/pharmacology ; Tumor Necrosis Factor-alpha/metabolism ; Neoplasm Recurrence, Local/immunology
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Long-term outcome and eligibility of radiofrequency ablation for hepatocellular carcinoma over 3.0 cm in diameter.
Autorzy:
Tanaka T; Department of Gastroenterology and Medicine, Faculty of Medicine, Fukuoka University, 7-45-1, Nanakuma, Jonan-Ku, Fukuoka, 814-0180, Japan. .
Takata K; Department of Gastroenterology and Medicine, Faculty of Medicine, Fukuoka University, 7-45-1, Nanakuma, Jonan-Ku, Fukuoka, 814-0180, Japan.
Miyayama T; Department of Gastroenterology and Medicine, Faculty of Medicine, Fukuoka University, 7-45-1, Nanakuma, Jonan-Ku, Fukuoka, 814-0180, Japan.
Shibata K; Department of Gastroenterology and Medicine, Faculty of Medicine, Fukuoka University, 7-45-1, Nanakuma, Jonan-Ku, Fukuoka, 814-0180, Japan.
Fukuda H; Department of Gastroenterology and Medicine, Faculty of Medicine, Fukuoka University, 7-45-1, Nanakuma, Jonan-Ku, Fukuoka, 814-0180, Japan.
Yamauchi R; Department of Gastroenterology and Medicine, Faculty of Medicine, Fukuoka University, 7-45-1, Nanakuma, Jonan-Ku, Fukuoka, 814-0180, Japan.
Fukunaga A; Department of Gastroenterology and Medicine, Faculty of Medicine, Fukuoka University, 7-45-1, Nanakuma, Jonan-Ku, Fukuoka, 814-0180, Japan.
Yokoyama K; Department of Gastroenterology and Medicine, Faculty of Medicine, Fukuoka University, 7-45-1, Nanakuma, Jonan-Ku, Fukuoka, 814-0180, Japan.
Shakado S; Department of Gastroenterology and Medicine, Faculty of Medicine, Fukuoka University, 7-45-1, Nanakuma, Jonan-Ku, Fukuoka, 814-0180, Japan.
Sakisaka S; Department of Gastroenterology and Medicine, Faculty of Medicine, Fukuoka University, 7-45-1, Nanakuma, Jonan-Ku, Fukuoka, 814-0180, Japan.
Hirai F; Department of Gastroenterology and Medicine, Faculty of Medicine, Fukuoka University, 7-45-1, Nanakuma, Jonan-Ku, Fukuoka, 814-0180, Japan.
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2023 Sep 28; Vol. 13 (1), pp. 16286. Date of Electronic Publication: 2023 Sep 28.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Hepatocellular*/pathology
Liver Neoplasms*/pathology
Catheter Ablation*/adverse effects
Radiofrequency Ablation*
Humans ; Treatment Outcome ; Neoplasm Recurrence, Local/pathology ; Retrospective Studies
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Transhepatectomy combined with arterial chemoembolization and transcatheter arterial chemoembolization in the treatment of hepatocellular carcinoma: a clinical prognostic analysis.
Autorzy:
Liu X; Department of Oncology, Affiliated Hospital of Southwest Medical University, Luzhou, China.; Department of Radiophysics and Technology, Shandong First Medical University (Shandong Academy of Medical Sciences), Shandong Institute of Cancer Prevention and Treatment (Shandong Cancer Hospital), Jinan, China.
Li H; Department of Radiophysics and Technology, Shandong First Medical University (Shandong Academy of Medical Sciences), Shandong Institute of Cancer Prevention and Treatment (Shandong Cancer Hospital), Jinan, China.; Graduate Department of Shandong First Medical University (Shandong Academy of Medical Sciences), Jinan, China.
Wang F; Department of General Surgery, Luxian People's Hospital, Luzhou, China.
Su K; Department of Oncology, Affiliated Hospital of Southwest Medical University, Luzhou, China.
He B; Department of Oncology, Affiliated Hospital of Southwest Medical University, Luzhou, China.; Shandong Institute of Cancer Prevention and Treatment (Shandong Cancer Hospital), Department of Radiotherapy, Shandong First Medical University (Shandong Academy of Medical Sciences), Jinan, China.
He J; Department of Oncology, Affiliated Hospital of Southwest Medical University, Luzhou, China.; Shandong Institute of Cancer Prevention and Treatment (Shandong Cancer Hospital), Department of Radiotherapy, Shandong First Medical University (Shandong Academy of Medical Sciences), Jinan, China.
Zhong J; Department of Oncology, Affiliated Hospital of Southwest Medical University, Luzhou, China.; Shandong Institute of Cancer Prevention and Treatment (Shandong Cancer Hospital), Department of Radiotherapy, Shandong First Medical University (Shandong Academy of Medical Sciences), Jinan, China.
Han Y; Department of Oncology, Affiliated Hospital of Southwest Medical University, Luzhou, China. .
Li Z; Department of Radiophysics and Technology, Shandong First Medical University (Shandong Academy of Medical Sciences), Shandong Institute of Cancer Prevention and Treatment (Shandong Cancer Hospital), Jinan, China. .
Pokaż więcej
Źródło:
BMC gastroenterology [BMC Gastroenterol] 2023 Sep 05; Vol. 23 (1), pp. 299. Date of Electronic Publication: 2023 Sep 05.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Hepatocellular*
Chemoembolization, Therapeutic*
Liver Neoplasms*
Humans ; Prognosis ; Retrospective Studies ; Neoplasm Recurrence, Local ; Lymphatic Metastasis
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
A Case of Curative Treatment with Apatinib and Camrelizumab Following Liver Resection for Advanced Hepatocellular Carcinoma.
Autorzy:
Huang J; Department of Hepatobiliary Surgery, Guangxi Medical University Cancer Hospital, Nanning 530021, China.
Liang R; Department of Digestive Oncology, Guangxi Medical University Cancer Hospital, Nanning 530021, China.
Lu C; Department of Hepatobiliary Surgery, Guangxi Medical University Cancer Hospital, Nanning 530021, China.
Lu L; Department of Digestive Oncology, Guangxi Medical University Cancer Hospital, Nanning 530021, China.
Li S; Department of Digestive Oncology, Guangxi Medical University Cancer Hospital, Nanning 530021, China.
Tang M; Department of Hepatobiliary Surgery, Guangxi Medical University Cancer Hospital, Nanning 530021, China.
Huang X; Department of Digestive Oncology, Guangxi Medical University Cancer Hospital, Nanning 530021, China.
Huang S; Department of Digestive Oncology, Guangxi Medical University Cancer Hospital, Nanning 530021, China.
Mai R; Department of Hepatobiliary Surgery, Guangxi Medical University Cancer Hospital, Nanning 530021, China.
Gao X; Department of Digestive Oncology, Guangxi Medical University Cancer Hospital, Nanning 530021, China.
Li S; Department of Hepatobiliary Surgery, Guangxi Medical University Cancer Hospital, Nanning 530021, China.
Zeng C; Department of Hepatobiliary Surgery, Guangxi Medical University Cancer Hospital, Nanning 530021, China.
Lin Y; Department of Digestive Oncology, Guangxi Medical University Cancer Hospital, Nanning 530021, China.
Ye J; Department of Hepatobiliary Surgery, Guangxi Medical University Cancer Hospital, Nanning 530021, China.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2023 Aug 30; Vol. 24 (17). Date of Electronic Publication: 2023 Aug 30.
Typ publikacji:
Case Reports
MeSH Terms:
Carcinoma, Hepatocellular*/drug therapy
Carcinoma, Hepatocellular*/surgery
Liver Neoplasms*/drug therapy
Humans ; Hepatectomy ; Prospective Studies ; Neoplasm Recurrence, Local/drug therapy
Raport
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Real-world practice of conversion surgery for unresectable hepatocellular carcinoma - a single center data of 26 consecutive patients.
Autorzy:
Zhang B; Department of Hepatobiliary Surgery, Shandong Cancer Hospital Affiliated to Shandong First Medical University, 440 Jiyan Road, Huaiyin District, Jinan, 250117, China.
Shi X; Department of Hepatobiliary Surgery, Shandong Cancer Hospital Affiliated to Shandong First Medical University, 440 Jiyan Road, Huaiyin District, Jinan, 250117, China.
Cui K; Department of Hepatobiliary Surgery, Shandong Cancer Hospital Affiliated to Shandong First Medical University, 440 Jiyan Road, Huaiyin District, Jinan, 250117, China.
Li Z; Department of Hepatobiliary Surgery, Shandong Cancer Hospital Affiliated to Shandong First Medical University, 440 Jiyan Road, Huaiyin District, Jinan, 250117, China.
Li L; Department of Hepatobiliary Surgery, Shandong Cancer Hospital Affiliated to Shandong First Medical University, 440 Jiyan Road, Huaiyin District, Jinan, 250117, China.
Liu Z; Department of Hepatobiliary Surgery, Shandong Cancer Hospital Affiliated to Shandong First Medical University, 440 Jiyan Road, Huaiyin District, Jinan, 250117, China.
Zhang C; Department of Hepatobiliary Surgery, Shandong Cancer Hospital Affiliated to Shandong First Medical University, 440 Jiyan Road, Huaiyin District, Jinan, 250117, China.
Sun P; Department of Hepatobiliary Surgery, Shandong Cancer Hospital Affiliated to Shandong First Medical University, 440 Jiyan Road, Huaiyin District, Jinan, 250117, China.
Zhong J; Department of Hepatobiliary Surgery, Shandong Cancer Hospital Affiliated to Shandong First Medical University, 440 Jiyan Road, Huaiyin District, Jinan, 250117, China.
Sun Z; Department of Hepatobiliary Surgery, Shandong Cancer Hospital Affiliated to Shandong First Medical University, 440 Jiyan Road, Huaiyin District, Jinan, 250117, China.; Shandong First Medical University, 6699 Qingdao Road, Huaiyin District, Jinan, 250117, China.
Chang Z; Department of Hepatobiliary Surgery, Shandong Cancer Hospital Affiliated to Shandong First Medical University, 440 Jiyan Road, Huaiyin District, Jinan, 250117, China.; Shandong First Medical University, 6699 Qingdao Road, Huaiyin District, Jinan, 250117, China.
Ma Z; The Fourth People's Hospital of Jinan, Jinan, 250031, China.
Gordon-Weeks A; Nuffield Department of Surgical Sciences, University of Oxford, Oxford, OX3 9DU, United Kingdom.
Li M; Department of Hepatobiliary Surgery, Shandong Cancer Hospital Affiliated to Shandong First Medical University, 440 Jiyan Road, Huaiyin District, Jinan, 250117, China. .; Shandong First Medical University, 6699 Qingdao Road, Huaiyin District, Jinan, 250117, China. .
Zhao L; Department of Hepatobiliary Surgery, Shandong Cancer Hospital Affiliated to Shandong First Medical University, 440 Jiyan Road, Huaiyin District, Jinan, 250117, China. .
Pokaż więcej
Źródło:
BMC cancer [BMC Cancer] 2023 May 20; Vol. 23 (1), pp. 465. Date of Electronic Publication: 2023 May 20.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Hepatocellular*/surgery
Carcinoma, Hepatocellular*/pathology
Liver Neoplasms*/surgery
Liver Neoplasms*/pathology
Humans ; Retrospective Studies ; Neoplasm Recurrence, Local/surgery ; Neoplasm Recurrence, Local/pathology ; Combined Modality Therapy
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Immune System and Hepatocellular Carcinoma (HCC): New Insights into HCC Progression.
Autorzy:
Kotsari M; Physiology Laboratory, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece.
Dimopoulou V; Physiology Laboratory, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece.
Koskinas J; B' Department of Medicine, Hippokration Hospital, National and Kapodistrian University of Athens, 11527 Athens, Greece.
Armakolas A; Physiology Laboratory, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2023 Jul 14; Vol. 24 (14). Date of Electronic Publication: 2023 Jul 14.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Carcinoma, Hepatocellular*/pathology
Liver Neoplasms*/pathology
Humans ; Neoplasm Recurrence, Local ; Immunotherapy ; Tumor Microenvironment ; Immune System/pathology
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Nomograms for postsurgical extrahepatic recurrence prediction of hepatocellular carcinoma based on presurgical circulating tumor cell status and clinicopathological factors.
Autorzy:
Wei HW; Department of Hepatobiliary Surgery, Guangxi Medical University Cancer Hospital, Nanning, China.; Key Laboratory of Early Prevention and Treatment for Regional High Frequency Tumor, Ministry of Education, Nanning, China.
Qin SL; Department of Hepatobiliary Surgery, Guangxi Medical University Cancer Hospital, Nanning, China.; Key Laboratory of Early Prevention and Treatment for Regional High Frequency Tumor, Ministry of Education, Nanning, China.
Xu JX; Department of Hepatobiliary Surgery, Guangxi Medical University Cancer Hospital, Nanning, China.; Key Laboratory of Early Prevention and Treatment for Regional High Frequency Tumor, Ministry of Education, Nanning, China.
Huang YY; Department of Hepatobiliary Surgery, Guangxi Medical University Cancer Hospital, Nanning, China.; Key Laboratory of Early Prevention and Treatment for Regional High Frequency Tumor, Ministry of Education, Nanning, China.
Chen YY; Department of Ultrasound, First Affiliated Hospital of Guangxi Medical University, Nanning, China.
Ma L; Department of Hepatobiliary Surgery, Guangxi Medical University Cancer Hospital, Nanning, China.; Key Laboratory of Early Prevention and Treatment for Regional High Frequency Tumor, Ministry of Education, Nanning, China.; Guangxi Liver Cancer Diagnosis and Treatment Engineering and Technology Research Center, Nanning, China.
Qi LN; Department of Hepatobiliary Surgery, Guangxi Medical University Cancer Hospital, Nanning, China.; Key Laboratory of Early Prevention and Treatment for Regional High Frequency Tumor, Ministry of Education, Nanning, China.; Guangxi Liver Cancer Diagnosis and Treatment Engineering and Technology Research Center, Nanning, China.
Pokaż więcej
Źródło:
Cancer medicine [Cancer Med] 2023 Jul; Vol. 12 (14), pp. 15065-15078. Date of Electronic Publication: 2023 Jun 20.
Typ publikacji:
Randomized Controlled Trial; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Carcinoma, Hepatocellular*/pathology
Liver Neoplasms*/pathology
Neoplastic Cells, Circulating*
Humans ; Nomograms ; Hepatectomy ; Prognosis ; Neoplasm Recurrence, Local/pathology ; Retrospective Studies
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Wyświetlanie 1-20 z 694

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies